Global Atherectomy and Intravascular Lithotripsy (IVL) Devices Market, By Device Type (Atherectomy Devices, Intravascular Lithotripsy (IVL) Devices), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) – Industry Trends and Forecast to 2031.
Atherectomy and Intravascular Lithotripsy (IVL) Devices Market Analysis and Size
As per a study published in the national journal Urolithiasis in February 2021, the incidence of nephrolithiasis has been increasing every year, with an estimated incidence rate of 10.10% in the U.S. Thus, the increasing global prevalence of urolithiasis necessitates safe, efficacious, and affordable treatment for urolithiasis. Over the years, lithotripsy has become the most preferred method for the treatment of kidney stones, mainly due to the advantage of its relative safety, low cost, less recovery time, and positive patient outcomes.
Data Bridge Market Research analyses that the global atherectomy & intravascular lithotripsy (IVL) devices market which was USD 849.86 million in 2023, expected to reach up to USD 1,353.52 million by 2031, and is expected to undergo a CAGR of 5.99% during the forecast period. This indicates the market value. “Atherectomy Devices” dominates the device type segment of the global atherectomy & intravascular lithotripsy (IVL) devices market owing to the growing demand for better methods for treatment in patients. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable to 2016-2021) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, and Pricing in USD |
|
Segments Covered |
Device Type (Atherectomy Devices, Intravascular Lithotripsy (IVL) Devices), End User (Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tenders, Retail Sales, Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
Straub Medical AG (Switzerland), Biotronik (Germany), C.R. Bard, Inc. (U.S.), Avinger (U.S.), Medtronic (Ireland), Koninklijke Philips N.V. (Netherlands), Boston Scientific Corporation (U.S.), Cardiovascular Systems (U.S.), EDAP TMS (France), Olympus Corporation (Japan), Dornier MedTech (Germany), Becton Dickinson and Company (U.S.), Storz Medical AG (Germany), DirexGroup (Germany), Elmed Medical Systems (Turkey), Siemens Healthineers AG (Germany) |
|
Market Opportunities |
|
Market Definition
Atherectomy is a minimally invasive procedure used to remove plaque buildup from inside blood vessels. The procedure involves the use of specialized devices known as atherectomy devices, which are inserted into the affected artery through a small incision, usually in the groin area. These devices are designed to break up or remove plaque, which consists of fatty deposits, calcium, and other substances that can narrow or block arteries, leading to conditions such as peripheral artery disease (PAD) or coronary artery disease (CAD). Atherectomy helps to restore blood flow and alleviate symptoms associated with narrowed or blocked arteries, such as leg pain or chest pain. Intravascular lithotripsy (IVL) is a novel technology used in the treatment of calcified coronary or peripheral artery lesions. It involves the use of a specialized balloon catheter equipped with lithotripsy emitters. These emitters deliver sonic pressure waves to disrupt and fracture calcified plaque within the artery, making it more compliant and easier to treat with conventional balloon angioplasty and stenting. IVL devices offer a less invasive alternative to traditional atherectomy techniques for treating heavily calcified lesions, reducing the risk of complications and improving outcomes for patients undergoing percutaneous coronary or peripheral interventions. Thus, increased accessibility to personal healthcare systems is the major driving factor in the market.
Global Atherectomy & Intravascular Lithotripsy (IVL) Devices Market Dynamics
Drivers
- Increasing Prevalence of Cardiovascular Diseases
The growing incidence of cardiovascular diseases, such as coronary artery disease (CAD) and peripheral artery disease (PAD), contributes significantly to the demand for Atherectomy and IVL devices. As the global population ages and lifestyles become more sedentary, the prevalence of these conditions continues to rise. Atherectomy and IVL procedures offer minimally invasive solutions for treating calcified lesions and restoring blood flow in narrowed or blocked arteries, making them essential tools in the management of cardiovascular diseases.
- Technological Advancements
Ongoing advancements in medical device technology, particularly in the design and functionality of Atherectomy and IVL devices, drive market growth. Innovations such as improved catheter designs, enhanced lithotripsy emitters, and the development of integrated imaging and guidance systems help to make these procedures safer, more effective, and easier to perform. Healthcare providers and patients increasingly seek out these advanced technologies to achieve better clinical outcomes and minimize procedural risks, further fueling market expansion.
Opportunities
- Expansion into Emerging Markets
There is significant potential for growth in emerging markets where there is an increasing demand for advanced medical technologies due to improving healthcare infrastructure and rising healthcare expenditures. Atherectomy and IVL device manufacturers can capitalize on these opportunities by expanding their presence in regions such as Asia-Pacific, Latin America, and the Middle East. By tailoring their products to the specific needs and preferences of these markets, companies can gain market share and establish themselves as key players in the global cardiovascular device market.
- Integration with Robotic-Assisted Interventions
Robotic-assisted interventions are gaining traction in the field of interventional cardiology, offering precise control and enhanced procedural accuracy. Atherectomy and IVL device manufacturers can explore opportunities to integrate their devices with robotic platforms, enabling clinicians to perform complex procedures with greater efficiency and precision. By leveraging robotics technology, these devices can potentially reduce procedural time, minimize radiation exposure, and improve patient outcomes.
Restraints/Challenges
- Cost Constraints and Reimbursement Challenges
A significant restraint in the adoption of Atherectomy and IVL devices is the cost associated with these procedures and devices. These technologies often come with a higher price tag compared to traditional treatment options, which can pose challenges for healthcare providers, patients, and payers, particularly in regions with limited healthcare budgets. In addition, reimbursement policies and rates for Atherectomy and IVL procedures may vary between healthcare systems and insurance providers, leading to uncertainty and potential financial barriers to access. Addressing these cost constraints and navigating reimbursement challenges is essential to ensure widespread adoption and market penetration of Atherectomy and IVL devices.
- Limited Clinical Evidence and Long-Term Outcomes
While Atherectomy and IVL devices have demonstrated promising results in the treatment of calcified lesions, there is still a need for robust clinical evidence supporting their safety, efficacy, and long-term outcomes, especially in comparison to conventional treatment modalities. Clinical studies evaluating the effectiveness of these devices in various patient populations and clinical scenarios are ongoing, but generating comprehensive data may take time. Furthermore, ensuring consistent follow-up and monitoring of patients over extended periods is essential to assess the durability of treatment outcomes and identify any potential late complications.
This global atherectomy & intravascular lithotripsy (IVL) devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global atherectomy & intravascular lithotripsy (IVL) devices market contact Data Bridge Market Research for an analyst brief, our team will help you make an informed market decision to achieve market growth.
Recent Developments
- In March 2022, Shockwave Medical, Inc. globally launched its new peripheral intravascular lithotripsy (IVL) catheter, Shockwave M5+ peripheral IVL catheter after receiving both CE Mark and USFDA clearance. The device is specifically designed to reduce the time of IVL treatment, offer alternative access options, and expand access the IVL therapy to patients with larger vessel sizes
- In November 2021, Shockwave Medical Inc. provided the safety and effectiveness of coronary Intravascular Lithotripsy (IVL) for the treatment of Intravascular Lithotripsy (IVL)
Global Atherectomy & Intravascular Lithotripsy (IVL) Devices Market Scope
The global atherectomy & intravascular lithotripsy (IVL) devices market is segmented on the basis of device type, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Device Type
- Atherectomy Devices
- Intravascular Lithotripsy (IVL) Devices
End User
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- Others
Distribution Channel
- Direct Tenders
- Retail Sales
- Others
Global Atherectomy & Intravascular Lithotripsy (IVL) Devices Market Regional Analysis/Insights
The global atherectomy & intravascular lithotripsy (IVL) devices market is analyzed and market size insights and trends are provided by country, device type, end user, and distribution channel as referenced above.
The countries covered in the global atherectomy & intravascular lithotripsy (IVL) devices market report are U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America is the region dominates the global atherectomy & intravascular lithotripsy (IVL) devices market because of the strong base of healthcare facilities, the strong presence of major players in the market, the extraordinary healthcare infrastructure, and the large pool of patients.
Asia-Pacific region is expected to witness significant growth during the forecast period of 2024 to 2031 due to the increase in government initiatives to promote healthcare, the rising health awareness among the people and growing demand for advanced medical technology for diagnosis and treatment procedures, the large population pool, and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends, and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of domestic tariffs, and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The global atherectomy & intravascular lithotripsy (IVL) devices market also provides you with a detailed market analysis for every country's growth in healthcare expenditure for capital equipment, installed base of different kinds of products for the global atherectomy & intravascular lithotripsy (IVL) devices market, the impact of technology using lifeline curves and changes in healthcare regulatory scenarios and their impact on the global atherectomy & intravascular lithotripsy (IVL) devices market.
Competitive Landscape and Global Atherectomy & Intravascular Lithotripsy (IVL) Devices Market Share Analysis
The global atherectomy & intravascular lithotripsy (IVL) devices market competitive landscape provides details by competitors. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width, and breadth, application dominance. The above data points provided are only related to the companies' focus related to the global atherectomy & intravascular lithotripsy (IVL) devices market.
Some of the major players operating in the global atherectomy & intravascular lithotripsy (IVL) devices market are:
- Straub Medical AG (Switzerland)
- Biotronik (Germany)
- C.R. Bard, Inc. (U.S.)
- Avinger (U.S.)
- Medtronic (Ireland)
- Koninklijke Philips N.V. (Netherlands)
- Boston Scientific Corporation (U.S.)
- Cardiovascular Systems (U.S.)
- EDAP TMS (France)
- Olympus Corporation (Japan)
- Dornier MedTech (Germany)
- Becton Dickinson and Company (U.S.)
- Storz Medical AG (Germany)
- DirexGroup (Germany)
- Elmed Medical Systems (Turkey)
- Siemens Healthineers AG (Germany)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
